🚀 VC round data is live in beta, check it out!
Eckert & Ziegler Valuation Multiples
Discover revenue and EBITDA valuation multiples for Eckert & Ziegler and similar public comparables like CareDx, Cosmo Advanced Materials, Daejoo Electronic, Azenta and more.
Eckert & Ziegler Overview
About Eckert & Ziegler
Eckert & Ziegler SE is a provider of isotope technology for medical, scientific, and industrial use. The company is predominantly engaged in the business of cancer therapy, nuclear imaging, and industrial metrology. The company's segments are Medical, Isotope Products, and Other. The Isotope Products segment, which generates key revenue, manufactures and distributes standards and radiation sources for medical and industrial purposes. The Medical segment provides pharmaceutical-quality radioactive ingredients and markets products for the treatment and diagnosis of cancers. The Other segment comprises the items of the holding company. Geographically, the company generates a majority of its revenue from Europe and the rest from North America, Asia/Pacific, and other regions.
Founded
1997
HQ
Employees
1.1K
Website
Financials (LTM)
EV
$975M
Eckert & Ziegler Financials
Eckert & Ziegler reported last 12-month revenue of $364M and EBITDA of $106M.
In the same LTM period, Eckert & Ziegler generated $176M in gross profit, $106M in EBITDA, and $57M in net income.
Eckert & Ziegler P&L
In the most recent fiscal year, Eckert & Ziegler reported revenue of $360M and EBITDA of $109M.
Eckert & Ziegler expects next 12-month revenue of XXX and NTM EBITDA of XXX
| LTM | NTM | Last FY | FY 2026 | FY 2027 | FY 2028 | |
|---|---|---|---|---|---|---|
| Revenue | $364M | XXX | $360M | XXX | XXX | XXX |
| Gross Profit | $176M | XXX | $177M | XXX | XXX | XXX |
| Gross Margin | 49% | XXX | 49% | XXX | XXX | XXX |
| EBITDA | $106M | XXX | $109M | XXX | XXX | XXX |
| EBITDA Margin | 29% | XXX | 30% | XXX | XXX | XXX |
| EBIT Margin | 25% | XXX | 25% | XXX | XXX | XXX |
| Net Profit | $57M | XXX | $56M | XXX | XXX | XXX |
| Net Margin | 16% | XXX | 16% | XXX | XXX | XXX |
Financial data powered by Morningstar, Inc.
Eckert & Ziegler Stock Performance
Eckert & Ziegler has current market cap of $1B, and enterprise value of $975M.
Eckert & Ziegler's stock price is $16.96.
| EV | Market Cap | Price 1D | Price 1M | Price 3M | Price 12M | EPS |
|---|---|---|---|---|---|---|
| $975M | $1B | 0.1% | XXX | XXX | XXX | $0.90 |
Benchmark Trading Valuation Multiples by Industry
Sign up to access valuation multiples like growth-adjusted P/E, Rule of 40, next 12-month EV/Revenue, EBITDA multiples by industry, consensus analyst estimates and many more.
Start Free TrialEckert & Ziegler Valuation Multiples
Eckert & Ziegler trades at 2.7x EV/Revenue multiple, and 9.2x EV/EBITDA.
Eckert & Ziegler Financial Valuation Multiples
As of March 29, 2026, Eckert & Ziegler has market cap of $1B and EV of $975M.
Equity research analysts estimate Eckert & Ziegler's 2025E EV/Revenue multiple at XXX and 2025E EV/EBITDA multiple at XXX
Eckert & Ziegler has a P/E ratio of 18.5x.
| LTM | NTM | Last FY | FY 2026 | FY 2027 | FY 2028 | |
|---|---|---|---|---|---|---|
| Market cap (current) | $1B | XXX | $1B | XXX | XXX | XXX |
| EV (current) | $975M | XXX | $975M | XXX | XXX | XXX |
| EV/Revenue | 2.7x | XXX | 2.7x | XXX | XXX | XXX |
| EV/EBITDA | 9.2x | XXX | 9.0x | XXX | XXX | XXX |
| EV/EBIT | 10.8x | XXX | 10.9x | XXX | XXX | XXX |
| EV/Gross Profit | 5.5x | XXX | 5.5x | XXX | XXX | XXX |
| P/E | 18.5x | XXX | 18.8x | XXX | XXX | XXX |
| EV/FCF | 28.1x | XXX | 26.1x | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Verified Eckert & Ziegler Valuation Multiples
Access all public comps and forward-looking valuation multiples like EV/Revenue in 2027, based on consensus analyst estimates. Powered by FactSet and Morningstar.
Eckert & Ziegler Margins & Growth Rates
Eckert & Ziegler's revenue in the last 12 month grew by 5%.
Eckert & Ziegler's revenue per employee in the last FY averaged $0.3M.
Eckert & Ziegler's rule of 40 is 34% (metric relevant for SaaS companies only, counted as combined revenue growth rate and EBITDA margin).
Eckert & Ziegler's rule of X is 42% (created by Bessemer, rule of X is another metric to measure SaaS companies, ~1.5x stronger vs. the traditional Rule of 40, counted as revenue growth rate multiplied by 2.5 plus EBITDA margin).
Eckert & Ziegler Operational Valuation Multiples
| LTM | NTM | Last FY | FY 2026 | FY 2027 | FY 2028 | |
|---|---|---|---|---|---|---|
| Revenue Growth | 5% | XXX | 4% | XXX | XXX | XXX |
| EBITDA Margin | 29% | XXX | 30% | XXX | XXX | XXX |
| EBITDA Growth | 6% | XXX | 1% | XXX | XXX | XXX |
| Rule of 40 | — | XXX | 34% | XXX | XXX | XXX |
| Bessemer Rule of X | — | XXX | 42% | XXX | XXX | XXX |
| Revenue per Employee | — | XXX | $0.3M | XXX | XXX | XXX |
| S&M Expenses to Revenue | 9% | XXX | 4% | XXX | XXX | XXX |
| G&A Expenses to Revenue | 14% | XXX | 5% | XXX | XXX | XXX |
| R&D Expenses to Revenue | 0% | XXX | 2% | XXX | XXX | XXX |
| Opex to Revenue | — | XXX | 25% | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Eckert & Ziegler Public Comps
See public comps and valuation multiples for other Diagnostics & Genomics and Advanced Materials comps.
| EV/Revenue | EV/EBITDA | |||||
|---|---|---|---|---|---|---|
| LTM | 2026E | 2027E | LTM | 2026E | 2027E | |
| CareDx | XXX | XXX | XXX | XXX | XXX | XXX |
| Cosmo Advanced Materials | XXX | XXX | XXX | XXX | XXX | XXX |
| Daejoo Electronic | XXX | XXX | XXX | XXX | XXX | XXX |
| Azenta | XXX | XXX | XXX | XXX | XXX | XXX |
| Vazyme Biotech | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc.
Eckert & Ziegler M&A Activity
Eckert & Ziegler acquired XXX companies to date.
Last acquisition by Eckert & Ziegler was on XXXXXXXX, XXXXX. Eckert & Ziegler acquired XXXXXXXX for XXX (EV/Revenue multiple of XXX).
Latest Acquisitions by Eckert & Ziegler
| Acquired Company | Valuation | EV/Revenue | EV/EBITDA |
|---|---|---|---|
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
Get Verified M&A Valuation Multiples
Sign up to see revenue and EBITDA valuation multiples for 150K+ M&A deals.
Start Free TrialEckert & Ziegler Investment Activity
Eckert & Ziegler invested in XXX companies to date.
Eckert & Ziegler made its latest investment on XXXXXXXX, XXXXX. Eckert & Ziegler invested in XXXXXXXX for XXX (EV/Revenue multiple of XXX).
Latest Investments by Eckert & Ziegler
| Company | Valuation | EV/Revenue | EV/EBITDA |
|---|---|---|---|
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
Benchmark 350K+ Funding Rounds and Disclosed VC Valuation Multiples
Sign up to see data on 350K+ funding rounds and disclosed revenue and EBITDA valuation multiples, from seed, through growth stage, to pre-IPO.
Start Free TrialAbout Eckert & Ziegler
| When was Eckert & Ziegler founded? | Eckert & Ziegler was founded in 1997. |
| Where is Eckert & Ziegler headquartered? | Eckert & Ziegler is headquartered in Germany. |
| How many employees does Eckert & Ziegler have? | As of today, Eckert & Ziegler has over 1K employees. |
| Is Eckert & Ziegler publicly listed? | Yes, Eckert & Ziegler is a public company listed on Frankfurt Stock Exchange. |
| What is the stock symbol of Eckert & Ziegler? | Eckert & Ziegler trades under EUZ ticker. |
| When did Eckert & Ziegler go public? | Eckert & Ziegler went public in 1999. |
| Who are competitors of Eckert & Ziegler? | Eckert & Ziegler main competitors are CareDx, Cosmo Advanced Materials, Daejoo Electronic, Azenta. |
| What is the current market cap of Eckert & Ziegler? | Eckert & Ziegler's current market cap is $1B. |
| What is the current revenue of Eckert & Ziegler? | Eckert & Ziegler's last 12 months revenue is $364M. |
| What is the current revenue growth of Eckert & Ziegler? | Eckert & Ziegler revenue growth (NTM/LTM) is 5%. |
| What is the current EV/Revenue multiple of Eckert & Ziegler? | Current revenue multiple of Eckert & Ziegler is 2.7x. |
| Is Eckert & Ziegler profitable? | Yes, Eckert & Ziegler is EBITDA-positive (as of the last 12 months). |
| What is the current EBITDA of Eckert & Ziegler? | Eckert & Ziegler's last 12 months EBITDA is $106M. |
| What is Eckert & Ziegler's EBITDA margin? | Eckert & Ziegler's last 12 months EBITDA margin is 29%. |
| What is the current EV/EBITDA multiple of Eckert & Ziegler? | Current EBITDA multiple of Eckert & Ziegler is 9.2x. |
| What is the current FCF of Eckert & Ziegler? | Eckert & Ziegler's last 12 months FCF is $35M. |
| What is Eckert & Ziegler's FCF margin? | Eckert & Ziegler's last 12 months FCF margin is 10%. |
| What is the current EV/FCF multiple of Eckert & Ziegler? | Current FCF multiple of Eckert & Ziegler is 28.1x. |
Start Your
Free Trial Today
Try Multiples for free for 3 days. Got questions or need a demo? Schedule a call with us below.